Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion
Status and phase
Conditions
Treatments
Details and patient eligibility
About
To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.
Full description
Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- nulliparous adolescent and young women requesting levonorgestrel-releasing intrauterine device
Exclusion criteria
- pregnancy and contraindication or allergy to dinoprostone or contraindication to IUD insertion, chronic pelvic pain,pelvic inflammatory disease,analgesic intake 24 hours prior to IUD insertion.
Trial design
Primary purpose
Allocation
Interventional model
Masking
130 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal